Censured Indian Plant Gets USFDA Nod to Supply Trump-Touted Drug

March 24, 2020

U.S. regulators have lifted import restrictions on an Indian pharmaceutical company in an effort to increase supplies of a malaria drug touted by President Donald Trump as a potential coronavirus treatment.

Related Stories